Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.72
0.0000
Post-market: 27.56-0.1600-0.58%18:24 EDT
Volume:28.52M
Turnover:792.39M
Market Cap:157.61B
PE:36.48
High:28.19
Open:28.08
Low:27.69
Close:27.72
52wk High:29.21
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:1.03
T/O Rate:0.51%
Dividend:1.72
Dividend Rate:6.20%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.85
PE(LYR):20.32

Loading ...

Pfizer downgraded to Hold from Buy at HSBC

TIPRANKS
·
Jul 06

U.S. Research Roundup-east West Bancorp, First Citizens Bancshares, UMB Financial

Reuters
·
Jul 06

Trump’s FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Macro World​
·
Jul 06

Is Pfizer Stock Ready for a Breakout? New Data Tests Bulls

TIPRANKS
·
Jul 04

Analysts’ Top Healthcare Picks: Pyxis Oncology (PYXS), Pfizer (PFE)

TIPRANKS
·
Jul 03

Pfizer Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 03

NYSE Most Active Issues

Dow Jones
·
Jul 02

Pfizer Expands Migraine Strategy With New Rimegepant Redosing Study

TIPRANKS
·
Jul 02

Cboe data shows mixed options sentiment in Pfizer with shares down 0.77%

TIPRANKS
·
Jul 01

Market Chatter: US Committee Launches Probe Against Five Drugmakers over China Clinical Trials

MT Newswires Live
·
Jul 01

Pfizer Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 01

Pfizer’s Real‑World COVID-19 Vaccine Study Nears Data Reveal: What Investors Should Watch

TIPRANKS
·
Jul 01

U.S. House Committee Sends Letters to Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials

Reuters
·
Jun 30

Pfizer Confirms Receiving Letter from U.S. House Committee Probing China Drug Trials

THOMSON REUTERS
·
Jun 30

House China Panel Questions Bristol Myers, Pfizer on Trial Sites - Endpoints News

Reuters
·
Jun 30

NYSE Most Active Issues

Dow Jones
·
Jun 30

Gilead Sciences Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jun 30

Moderately bullish activity in Pfizer with shares up 0.1%

TIPRANKS
·
Jun 30

Pfizer Canada Ulc: Perioperative Option Approved in Canada for Patients with Muscle-invasive Bladder Cancer Unable to Receive Cisplatin-based Therapy

THOMSON REUTERS
·
Jun 29

Pfizer Glp-1 Drug Passes Preliminary Review for China Medical Insurance Drug List - Official Statement

THOMSON REUTERS
·
Jun 29